Table 2.
Demographic and clinical characteristics of patients
| Variables | Overall | Group | ||
|---|---|---|---|---|
|
| ||||
| Control | Smart After-Care | p-value | ||
| Age (years)* | 66.4, 66.0 (± 7.5) | 66.5, 66.0 (± 8.2) | 66.3, 65.0 (± 6.8) | 0.848 |
| BMI (kg/m2)* | 25.5, 25.1 (± 3.1) | 25.7, 25.5 (± 2.9) | 25.4, 24.7 (± 3.3) | 0.466 |
| Diabetes mellitus (%) | 41 (23.8) | 20 (23.3) | 21 (24.4) | 0.590 |
| Hypertension (%) | 98 (57.0) | 51 (59.3) | 47 (54.7) | 0.526 |
| Dyslipidemia (%) | 49 (28.5) | 22 (25.6) | 27 (31.4) | 0.405 |
| Smoking (%) | 0.429 | |||
| Never-smoker | 59 (34.3) | 32 (37.2) | 27 (31.4) | |
| Previous smoker | 55 (32.0) | 29 (33.7) | 26 (30.2) | |
| Current smoker | 58 (33.7) | 25 (29.1) | 33 (38.4) | |
| Alcohol (%) | 0.937 | |||
| None | 130 (75.6) | 64 (74.4) | 66 (76.7) | |
| Yes | 40 (23.3) | 21 (24.4) | 19 (22.1) | |
| Preoperative PSA (ng/mL)* | 89.5, 22.4 (± 220.7) | 100.8, 21.1 (± 285.9) | 78.1, 23.2 (± 126.5) | 0.502 |
| Clinical T stage (%) | 0.842 | |||
| T1a | 1 (0.6) | 1 (1.2) | 0 (0) | |
| T1b | 0 (0) | 0 (0) | 0 (0) | |
| T1c | 4 (2.3) | 3 (3.5) | 1 (1.2) | |
| T2a | 9 (5.2) | 5 (5.8) | 4 (4.7) | |
| T2b | 13 (7.6) | 5 (5.8) | 8 (9.3) | |
| T2c | 37 (21.5) | 18 (20.9) | 19 (22.1) | |
| T3a | 41 (23.8) | 22 (25.8) | 19 (22.1) | |
| T3b | 55 (32.0) | 27 (31.4) | 28 (32.6) | |
| T4 | 11 (6.4) | 5 (5.8) | 6 (7.0) | |
| Clinical N stage (%) | 0.273 | |||
| N0 | 126 (73.3) | 67 (77.9) | 59 (68.6) | |
| N1 | 45 (26.2) | 19 (22.1) | 26 (30.2) | |
| Clinical M stage (%) | 0.604 | |||
| M0 | 143 (83.1) | 72 (83.7) | 71 (82.6) | |
| M1 | 28 (16.3) | 14 (16.3) | 14 (16.3) | |
| Biopsy Gleason score (%) | 0.651 | |||
| ≤ 6 | 23 (13.6) | 10 (11.9) | 13 (15.3) | |
| 7 (3+4) | 31 (18.3) | 13 (15.5) | 18 (21.2) | |
| 7 (4+3) | 27 (16.0) | 14 (16.7) | 13 (15.3) | |
| ≥ 8 | 88 (52.1) | 47 (56.0) | 41 (48.2) | |
| Treatment modality (%) | ||||
| Radical prostatectomy | 100 (58.1) | 45 (52.3) | 55 (64.0) | 0.122 |
| Radiation therapy | 90 (52.3) | 46 (53.5) | 44 (51.2) | 0.760 |
*
Values are expressed as mean, median (± SD).
BMI, body mass index; PSA, prostate-specific antigen.